caa a22 4500 477036775 CHVBK 20180405111307.0 cr unu---uuuuu 170330e19960201xx s 000 0 eng 10.1007/s002689900030 doi (NATIONALLICENCE)springer-10.1007/s002689900030 Treatment of Liver Metastases of Carcinoid Tumors [Elektronische Daten] [Håkan Ahlman, Gunnel Westberg, Bo Wängberg, Ola Nilsson, Ulf Tylén, Tore Scherstén, Lars-Erik Tisell] Abstract. Liver metastases imply a major problem in patients with carcinoid tumors. Patients with localized disease should always undergo resection for cure. Patients with distant metastatic disease can also undergo resection for potential cure or symptom palliation because of the slow growth rate of many carcinoid tumors. In patients with the midgut carcinoid syndrome and bilobar hepatic disease we have performed primary surgery to relieve such symptoms as intestinal obstruction and ischemia, followed by successive embolizations of the hepatic arteries to reduce functional tumor burden in the liver. For optimal palliation, all patients with residual tumor were treated by octreotide. In a consecutive series of 64 patients with the midgut carcinoid syndrome we thus attained a 5-year survival rate of 70%. Fourteen of the patients underwent intentionally curative surgery (e.g., primary surgery followed by liver surgery). Of these patients, none died from their tumor disease during the period of study. The value of adjunctive interferon therapy is currently under evaluation.: 1996 by the Société Internationale de Chir, ugie Ahlman Håkan Department of Surgery, Sahlgren University Hospital, Göteborg University, S-413 45 Göteborg, Sweden, SE aut Westberg Gunnel Department of Surgery, Sahlgren University Hospital, Göteborg University, S-413 45 Göteborg, Sweden, SE aut Wängberg Bo Department of Surgery, Sahlgren University Hospital, Göteborg University, S-413 45 Göteborg, Sweden, SE aut Nilsson Ola Department of Pathology, Sahlgren University Hospital, Göteborg University, S-413 45 Göteborg, Sweden, SE aut Tylén Ulf Department of Radiology, Sahlgren University Hospital, Göteborg University, S-413 45 Göteborg, Sweden, SE aut Scherstén Tore Department of Surgery, Sahlgren University Hospital, Göteborg University, S-413 45 Göteborg, Sweden, SE aut Tisell Lars-Erik Department of Surgery, Sahlgren University Hospital, Göteborg University, S-413 45 Göteborg, Sweden, SE aut https://doi.org/10.1007/s002689900030 text/html Onlinezugriff via DOI 1 research-article jats NATIONALLICENCE 856 40 https://doi.org/10.1007/s002689900030 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Ahlman Håkan Department of Surgery, Sahlgren University Hospital, Göteborg University, S-413 45 Göteborg, Sweden, SE aut NATIONALLICENCE 700 1- Westberg Gunnel Department of Surgery, Sahlgren University Hospital, Göteborg University, S-413 45 Göteborg, Sweden, SE aut NATIONALLICENCE 700 1- Wängberg Bo Department of Surgery, Sahlgren University Hospital, Göteborg University, S-413 45 Göteborg, Sweden, SE aut NATIONALLICENCE 700 1- Nilsson Ola Department of Pathology, Sahlgren University Hospital, Göteborg University, S-413 45 Göteborg, Sweden, SE aut NATIONALLICENCE 700 1- Tylén Ulf Department of Radiology, Sahlgren University Hospital, Göteborg University, S-413 45 Göteborg, Sweden, SE aut NATIONALLICENCE 700 1- Scherstén Tore Department of Surgery, Sahlgren University Hospital, Göteborg University, S-413 45 Göteborg, Sweden, SE aut NATIONALLICENCE 700 1- Tisell Lars-Erik Department of Surgery, Sahlgren University Hospital, Göteborg University, S-413 45 Göteborg, Sweden, SE aut Metadata rights reserved Springer special CC-BY-NC licence nationallicence BK010053 XK010053 XK010000 NATIONALLICENCE NATIONALLICENCE NL-springer